 |
HTDS Hard To Treat Diseases
Volatility kicking in volume picking up and I suspect it has to with holders tiring of holding with no immediate gratification but good opportunity to get in on a discounted PPS for those who would like to be part of the HTDS machine ...
Recent highlights : H1N1 ( FSDA ) approval http://eng.sfda.gov.cn/eng...Vaccinations...Hepatitis...Mergers...1 for 2 forward
split...cutting edge cancer research...uplist OTCBB... Reclaiming of IP rights ... AFRICA Opportunity ...
There's too much on the table and CEO TERRY YUAN is working hard to make HTDS profitable working machine ...
The company operates 2 medical subsidiaries in Serbia, Europe and Mainland China
HTDS is a parent co with operations in a East European medical company (Serbia) Slavica Bio Chem Co (formerly ReNuYu Biochmem PLC and ReNuYu Biochem Inc) see: (www.slavicabiochem.com) and in China Mellow Hope Inc. www.mellowhope.com
In Serbia the company's primary focus involves the enhancement and modification of existing approved drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV. Other interests include an on line cosmetics company.
Mellow Hope is China based and the biggest exporter of Biological Vaccines in China. It has a product line that encompasses vaccines for influenza, tetanus, diphtheria and other diseases; Blood based products including human rabies immunoglobulin; and active pharmaceutical ingredient (or APIs) for injection such as celestat in.
By Pasqualeww.
HOT OTC STOCKS
|
 |
 |
